概述

  • 产品名称Anti-C14orf130抗体
    参阅全部 C14orf130 一抗
  • 描述
    小鼠多克隆抗体to C14orf130
  • 经测试应用适用于: WBmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    Full length protein corresponding to amino acids 1-274 of Human C14orf130 (NP_060578.2).

  • 阳性对照
    • PC-12 cell lysate, Raw 264.7 cell lysate, Jurkat cell lysate, NIH/3T3 cell lysate, C14orf130 transfected 293T cell lysate

性能

  • 形式Liquid
  • 存放说明Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • 存储溶液Preservative: None
    Constituents: Whole serum
  • 纯度Whole antiserum
  • 克隆多克隆
  • 同种型IgG
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab88879 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
WB 1/500 - 1/1000. Predicted molecular weight: 48 kDa.

靶标

  • 相关性C14orf130 is a putative E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific amino-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation.
  • 数据库链接
  • 别名
    • 5730410I19Rik antibody
    • AA589405 antibody
    • AW557761 antibody
    • Chromosome 14 open reading frame 130 antibody
    • EC 6.3.2.- antibody
    • FLJ10483 antibody
    • MGC94098 antibody
    • MGC9518 antibody
    • N recognin 7 antibody
    • Putative E3 ubiquitin-protein ligase UBR7 antibody
    • RGD1359144 antibody
    • Ubiquitin protein ligase E3 component n-recognin 7 (putative) antibody
    • UBR7 antibody
    see all

Anti-C14orf130 antibody 图像

Anti-C14orf130 antibody (ab88879)参考文献

ab88879 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab88879.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"